$95.860
+0.278 (+0.29%)Al cierre
Noticias de CRH
Eventos de CRH
CRH Acquires Pisgah Stone Products to Enhance Northern Utah Business
CRH's Americas Materials business announced that it has acquired Pisgah Stone Products, a producer of high-quality aggregates in Northern Utah. The acquisition will provide CRH with additional aggregate reserves to support its long-term strategy in the region, where a growing economy is driving robust construction demand. "The Utah market continues to benefit from strong population growth, economic expansion and significant infrastructure investment," said Jason Jackson, President, CRH Americas Materials. "Pisgah's high-quality limestone reserves, strategic location, and strong cultural alignment with CRH make it an excellent fit for our growing Northern Utah business and will enhance our ability to serve customers across the Wasatch Front. We look forward to building on Pisgah's success and continuing to deliver outstanding service to customers throughout the region."
Sees 2026 Adjusted EBITDA at $8.1B-$8.5B
Sees 2026 adjusted EBITDA $8.1B-$8.5B. Sees 2026 CapEx $2.7B-$2.9B.
Company Reports Q2 Revenue of $10.8B, Beating Expectations
Reports Q2 revenue $10.8B, consensus $10.68B. Jim Mintern, Chief Executive Officer, stated "We delivered a strong Q2 performance driven by good commercial execution, favorable underlying demand and further contributions from acquisitions. Our unmatched scale, connected portfolio and leading performance supported higher profits and margin expansion against an inflationary cost backdrop. We remain focused on active portfolio management, completing three non-core divestitures, while reallocating capital into higher-growth, connected businesses. Backed by our robust balance sheet and financial capacity, we agreed the $8.5 billion acquisition of Arcosa, which will reinforce our position as the leading aggregates and critical infrastructure player in North America. Notwithstanding current geopolitical and macroeconomic uncertainties, we remain encouraged by the underlying demand across our key markets and are pleased to reaffirm our guidance for 2026 Net income, Adjusted EBITDA* and Diluted EPS, leaving us well positioned to deliver another year of growth and value creation."
Nasdaq Declines Amid Weakness in Tech Stocks
The major averages had a mixed finish, with the Nasdaq the loser amid weakness in technology stocks, most notably SpaceX. Peace negotiations between the U.S. and Iran have reportedly shown progress, helping push oil prices lower and reducing some of the inflation pressure that had worried investors in recent weeks. Of note, U.S. Treasury Secretary Scott Bessent said in a social media post that the Treasury Department has issued a temporary 60-day license to allow Iran to sell oil.At the same time, attention is shifting back toward the Federal Reserve and the possibility that rates stay elevated for longer. Markets this week are closely watching upcoming inflation data, particularly the PCE reading, as recent commentary has reinforced expectations that policymakers remain focused on controlling inflation rather than supporting asset prices.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Chevronwith Microsoftto power a data center in West TexasCRHArcosafor $150 per share in cashAbbVieApogee Therapeuticsfor $135.11 per share in cash, or $10.9BSpaceXhas signed a computing power deal with Reflection worth up to $6.3B,Texas AG Ken Paxtoninto Carnivalfollowing the company's April data breach2. WALL STREET CALLS:SpaceXwith a Sector Weight at KeyBancVisteonat JPMorgan and BarclaysRoth Capitala handful of exploration and production names, saying oil prices are close to a near-term bottomAccentureto Hold at TD CowenTE Connectivityto In Line at Evercore ISI3. AROUND THE WEB:Metais planning a $900M investment in Indian fintech startup Cred for a roughly 20% stake, alongside plans to appoint Cred founder Kunal Shah as the new leader of WhatsApp, Bloomberg' reportsBaldwin Groupis exploring a take-private transaction, Insurance Insider reportsRegenxbioChief Executive Curran Simpson said the Food and Drug Administration has agreed to reverse its rejection of an experimental gene therapy for a rare and fatal brain disease, WSJ saysCharles Schwabis working with Cboe Global Marketsto roll out prediction market contracts that allow customers to place yes-or-no wagers on the performance of the S&P 500, WSJ reportsJohn Jumper is leaving GoogleDeepMind to join Anthropic, Reuters says4. MOVERS:Gettyincreases after entering aDefinium Therapeuticsgains after announcing its Emerge studyMoonLakehigher in New York after announcingfrom its Phase 3 VELA-1 and VELA-2 trialsSable Offshorelower after entering into aVirgin Galacticfalls after filing to exchange $52.5M in5. EARNINGS/GUIDANCE:Ennis, with EPS and revenue higher year-over-yearHawkEye, with EPS missing consensusFervo Energy, with EPS lower year-over-yearMicron Technologytoon June 24FedExtoon June 23INDEXES:The Dow rose 148.01, or 0.29%, to 51,712.71, the Nasdaq lost 351.33, or 1.32%, to 26,166.60, and the S&P 500 declined 27.79, or 0.37%, to 7,472.79.
S&P 500 Declines Amid Weakness in Tech Stocks
The major averages were mixed near noon, with the S&P 500 in decline amid weakness in technology stocks and SpaceX. Peach negotiations between the U.S. and Iran have reportedly shown progress, helping push oil prices lower and reducing some of the inflation pressure that had worried investors in recent weeks. At the same time, attention is shifting back toward the Federal Reserve and the possibility that rates stay elevated for longer. Markets this week are closely watching upcoming inflation data, particularly the PCE reading, as recent commentary has reinforced expectations that policymakers remain focused on controlling inflation rather than supporting asset prices.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Chevronwith Microsoftto power a data center in West TexasCRHArcosafor $150 per share in cashAbbVieApogee Therapeuticsfor $135.11 per share in cash, or $10.9BSpaceXhas signed a computing power deal with Reflection worth up to $6.3B,ABCis launching a campaign urging viewer support amid FCC investigations,2. WALL STREET CALLS:SpaceXwith a Sector Weight at KeyBancVisteonat JPMorgan and BarclaysRoth Capitala handful of exploration and production names, saying oil prices are close to a near-term bottomAccentureto Hold at TD CowenTE Connectivityto In Line at Evercore ISI3. AROUND THE WEB:Metais planning a $900M investment in Indian fintech startup Cred for a roughly 20% stake, alongside plans to appoint Cred founder Kunal Shah as the new leader of WhatsApp, Bloomberg' reportsBaldwin Groupis exploring a take-private transaction, Insurance Insider reportsRegenxbioChief Executive Curran Simpson said the Food and Drug Administration has agreed to reverse its rejection of an experimental gene therapy for a rare and fatal brain disease, WSJ saysCharles Schwabis working with Cboe Global Marketsto roll out prediction market contracts that allow customers to place yes-or-no wagers on the performance of the S&P 500, WSJ reportsJohn Jumper is leaving GoogleDeepMind to join Anthropic, Reuters says4. MOVERS:Gettyincreases after entering aDefinium Therapeuticsgains after announcing its Emerge studyMoonLakehigher in New York after announcingfrom its Phase 3 VELA-1 and VELA-2 trialsSable Offshorelower after entering into a seniorVirgin Galacticfalls after filing toin convertible senior notes for shares5. EARNINGS/GUIDANCE:Ennis, with EPS and revenue higher year-over-yearHawkEye, with EPS missing consensusFervo Energy, with EPS lower year-over-yearMicron Technologyon June 24FedExon June 23INDEXES:Near midday, the Dow was up 0.36%, or 187.83, to 51,752.53, the Nasdaq was down 1.10%, or 290.88, to 26,227.05, and the S&P 500 was down 0.32%, or 24.32, to 7,476.26.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.